Literature DB >> 4293744

Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection.

R R Gutekunst, R J White, W P Edmondson, R M Chanock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4293744     DOI： 10.1093/oxfordjournals.aje.a120744

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  10 in total

1.  Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease.

Authors:  L K Crawford-Miksza; R N Nang; D P Schnurr
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant.

Authors:  M Gorziglia; A Z Kapikian
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.

Authors:  J van der Veen; M F Abarbanel; K G Oei
Journal:  J Hyg (Lond)       Date:  1968-12

Review 4.  Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.

Authors:  Saber Yezli; Jonathan A Otter
Journal:  Food Environ Virol       Date:  2011-03-16       Impact factor: 2.778

Review 5.  Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Authors:  L Jean Patterson; Marjorie Robert-Guroff
Journal:  Expert Opin Biol Ther       Date:  2008-09       Impact factor: 4.388

Review 6.  Prospects for oral replicating adenovirus-vectored vaccines.

Authors:  Cailin Deal; Andrew Pekosz; Gary Ketner
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

7.  Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.

Authors:  Kevin L Russell; Anthony W Hawksworth; Margaret A K Ryan; Jennifer Strickler; Marina Irvine; Christian J Hansen; Gregory C Gray; Joel C Gaydos
Journal:  Vaccine       Date:  2006-01-24       Impact factor: 3.641

8.  Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers.

Authors:  B A Dudding; P J Bartelloni; R M Scott; F H Top; P K Russell; E L Buescher
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

9.  Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011-20151.

Authors:  Adriana E Kajon; Daryl M Lamson; Camden R Bair; Xiaoyan Lu; Marie L Landry; Marilyn Menegus; Dean D Erdman; Kirsten St George
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

10.  Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.

Authors:  Wai-Hong Wu; Tanwee Alkutkar; Balasubramanyan Karanam; Richard B S Roden; Gary Ketner; Okechukwu A Ibeanu
Journal:  Virol J       Date:  2015-09-11       Impact factor: 4.099
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.